Bristol-Myers Squibb 2Q Revenues: $4.9 billion (+17%) 2Q Earnings: $1.2 billion (loss of $130k 2Q15) YTD Revenues: $9.3 billion (+13%) YTD Earnings: $2.4 billion (+124%) Comments: Growth in the quarter was driven by Opdivo, which grew by $718 million to $840 million; Eliquis, which grew 78% to $777 million; Orencia sales were up 29% to $593 million; Hepatitis C Franchise, which grew 14% to $546 million; and Sprycel, which grew 11% to $451 million. Baraclude sales were down 13% to ...